• K W Harris.
• Resp Care. 1988 Apr 1; 33 (4): 264-73.

AbstractHealth care costs continue to skyrocket, and a large portion of these costs can be attributed to technology. Some technology, such as oximetry, is relatively inexpensive compared to CAT scanning and magnetic resonance imaging. Therefore, it may elude close scrutiny and direct health care planning and, with little fanfare, drive up costs. Many of the new respiratory monitors and ventilators have not yet been subjected to the basic question: Do they affect morbidity and mortality? Technology assessment in this country is fraught with duplication of effort and complexity; the system is fragmented and in need of a strategic approach to equipment evaluation. There is meager information on cost analysis and little consensus on what needs to be done about the ethical dilemmas created by technology. Respiratory care practitioners have a significant role to play in medical device evaluation. Problem reporting of serious equipment malfunctions to the U.S. Pharmacopeia and manufacturers is essential. In-house product evaluation prior to purchase is prudent. Important feedback can be given to manufacturers through testing of prototype equipment, with the end result that our needs are met. Small departments may need to rely on information that is currently available. Laboratory and clinical research must be conducted to provide a scientific basis for the use of technology. Adequate assessment requires knowledgeable people in a position to perform the essential tasks. Respiratory care practitioners are a logical group to take an active role in the important tasks of thoroughly assessing the technologies we use.

10 keywords...

hide…